Search
New Psychoactive Substances – Designer Benzodiazepines
Gamma Hydroxybutyrate (GHB) as a new storm for Mental Health and Addiction Professionals: Insight from Developing Countries
New Psychoactive Substances (NPS): Synthetic Hallucinogens/ Synthetic Depressants
Quality Assurance (QA) of the Drug Treatment Services in Pakistan
Comorbid Psychiatric Disorders in Patients suffering from Substance Use Disorder
Tobacco Webinar Series: Tobacco Smoking Addiction - From Prevention to Treatment
Webinar | Risk & Protective Factors of Substance Use: Youth Focused Prevention
Webinar | Psychological Capital: Substance Use Disorder and Recovery process
Consequences of Tobacco Use (Gutka)
Consequences of Tobacco Use (Gutka)
By Haider Ali
Tobacco is frequently being used in two ways. Some people use smoke tobacco by using cigarette/ hukka, whereas some chew tobacco (gutka). Both methods of using tobacco are harmful for...
Drug Demand Reduction
Drug Demand Reduction
By Grainne Kenny
An estimated 200 million people, or 5% of the global population aged between 15-64yrs have used illicit drugs at least once in the past year. Britain and Ireland have the highest number of drug and...
Myths about Drug Abuse
Myths About Drug Abuse
By Haider Ali
People adhered to different myths regarding drug abuse problems. Some myths are culture or tradition related, some are deemed as demand of the situation and some of them are adhered according to own...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member